-+ 0.00%
-+ 0.00%
-+ 0.00%

Trust Gap Limits AI's Value in Pharma Decisions, Patsnap Survey Finds

PUBT·11/16/2026 22:23:14
Listen to the news
Trust Gap Limits AI's Value in Pharma Decisions, Patsnap Survey Finds
  • Patsnap's State of Pharma Intelligence 2026 survey of 130 senior leaders found trust and validation constrain AI-driven pharmaceutical decisions.
  • AI changed a decision outcome for 92% of respondents in the past six months; 58% view its intelligence as requiring validation.
  • China ranks as the leading external innovation opportunity for 45% of respondents; only 22% feel confident in their market visibility.
  • Only 23% produce initial intelligence on potential partners within two weeks; internal alignment is the leading screening constraint, cited by 48%.
  • Organizations with dedicated AI/ML staff report advanced automation at 27%, compared with 9% among those without.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Patsnap Pte Ltd. published the original content used to generate this news brief on November 16, 2026, and is solely responsible for the information contained therein.